PTGS2 and skin cancer: Chlorogenic acid could inhibit the activation of inflammatory factors, such as COX-2, NF-κB, and iNOS, in the mouse skin after 12-O-tetradecanoylphorbol-13-acetate treatment and prevent skin cancer [48].